Skip to main content
. Author manuscript; available in PMC: 2021 May 14.
Published in final edited form as: Dev Comp Immunol. 2020 Aug 29;114:103843. doi: 10.1016/j.dci.2020.103843

Figure 4.

Figure 4.

Virus titers are unaffected by prophylactically treating IAV infected pigs with α-GalCer (αGC). (A) Viral titers in nasal swabs from pigs in Experiment 1 that administrated α-GalCer (αGC) i.m. or i.n. 9 days prior to infection with CA04. (B-C) Viral titers in nasal swabs (B) and tissues 5 d.p.i. (C) from pigs in Experiment 2 that administered αGC i.n. 2 days before infection. Data are represented as mean ± SEM. Data were analyzed using the SAS PROC GLIMMIX procedure in SAS. No significant differences were detected among the infected groups.